Literature DB >> 2347434

Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia.

J S Yudkin1, R D Forrest, C A Jackson, A J Ryle, S Davie, B J Gould.   

Abstract

We have studied levels of glycated haemoglobin in a sample of 223 people aged over 40 years without known diabetes mellitus screened in a community study. Each had a glucose tolerance test and glycated haemoglobin measured by four methods - agar gel electrophoresis with and without removal of Schiff base, affinity chromatography and isoelectric focusing. The correlation coefficients between 2 h blood glucose and levels of glycated haemoglobin were between 0.43 and 0.64. This poor correlation was not explained on the basis of assay or biological variability of either 2 h blood glucose or glycated haemoglobin. Multiple regression analysis showed that other assays of glycated haemoglobin contributed to the variance of any single glycated haemoglobin value by 0.1%-52.9% (median 12.8%) compared to the variance of 18.6%-41.4% (median 30.8%) explained by 2 h blood glucose alone, suggesting that in a non-diabetic population, the degree of glucose intolerance may explain only one third of the variance of glycated haemoglobin levels, but other factors operate to produce consistent changes in levels of glycated haemoglobin. Investigation of 42 subjects with consistently high (20 subjects) or low (22 subjects) levels of glycated haemoglobin relative to their 2 h blood glucose level showed no difference in age, gender, body mass index, haemoglobin levels or smoking, although 50% of low glycators had impaired glucose tolerance. Neither ambient blood-glucose levels, as estimated on two five-point blood-glucose profiles, nor dietary intake of carbohydrate, starch, sugars, fibre or alcohol, explained the difference between high and low glycators. The determinants of the consistent interindividual differences in levels of glycated haemoglobin in non-diabetic subjects remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347434     DOI: 10.1007/bf00404798

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  Glycosylated hemoglobin assay and oral glucose tolerance test compared for detection of diabetes mellitus.

Authors:  R F Dods; C Bolmey
Journal:  Clin Chem       Date:  1979-05       Impact factor: 8.327

2.  m-Aminophenylboronate affinity ligands distinguish between nonenzymically glycosylated proteins and glycoproteins.

Authors:  B J Gould; P M Hall
Journal:  Clin Chim Acta       Date:  1987-03-16       Impact factor: 3.786

3.  Hemoglobin carbamylation in uremia.

Authors:  R Flückiger; W Harmon; W Meier; S Loo; K H Gabbay
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

4.  Measurement of glycosylated haemoglobins using an affinity chromatography method.

Authors:  B J Gould; P M Hall; J G Cook
Journal:  Clin Chim Acta       Date:  1982-10-13       Impact factor: 3.786

Review 5.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

6.  Haemoglobin A1c concentrations in men and women with diabetes.

Authors:  R B Jones; D I Johnston; S P Allison; I Peacock; D J Hosking; R B Tattersall
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

7.  Reproducibility of the new diagnostic criteria for impaired glucose tolerance.

Authors:  G Riccardi; O Vaccaro; A Rivellese; S Pignalosa; L Tutino; M Mancini
Journal:  Am J Epidemiol       Date:  1985-03       Impact factor: 4.897

8.  Haemoglobinopathies: a pitfall in the assessment of glycosylated haemoglobin by ion-exchange chromatography.

Authors:  C Eberentz-Lhomme; R Ducrocq; S Intrator; J Elion; E Nunez; R Assan
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

9.  Glycohemoglobins and glucose tolerance.

Authors:  A Lev-Ran; W P VanderLaan
Journal:  JAMA       Date:  1979-03-02       Impact factor: 56.272

10.  Glucose intolerance and hypertension in north London: the Islington Diabetes Survey.

Authors:  R D Forrest; C A Jackson; J S Yudkin
Journal:  Diabet Med       Date:  1986 Jul-Aug       Impact factor: 4.359

View more
  40 in total

Review 1.  Glycated haemoglobin in the year 2000.

Authors:  E S Kilpatrick
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

2.  HbA1c measurement.

Authors:  E S Kilpatrick
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

Review 3.  Do race and ethnicity impact hemoglobin A1c independent of glycemia?

Authors:  William H Herman
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.

Authors:  Roy W Beck; Crystal G Connor; Deborah M Mullen; David M Wesley; Richard M Bergenstal
Journal:  Diabetes Care       Date:  2017-08       Impact factor: 19.112

Review 5.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

6.  Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring.

Authors:  Roy Malka; David M Nathan; John M Higgins
Journal:  Sci Transl Med       Date:  2016-10-05       Impact factor: 17.956

7.  Differences in Hemoglobin A1c Between Hispanics/Latinos and Non-Hispanic Whites: An Analysis of the Hispanic Community Health Study/Study of Latinos and the 2007-2012 National Health and Nutrition Examination Survey.

Authors:  M Larissa Avilés-Santa; Lucy L Hsu; Mario Arredondo; Andy Menke; Ellen Werner; Bharat Thyagarajan; Gerardo Heiss; Yanping Teng; Neil Schneiderman; Aida L Giachello; Linda C Gallo; Gregory A Talavera; Catherine C Cowie
Journal:  Diabetes Care       Date:  2016-04-18       Impact factor: 19.112

Review 8.  Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.

Authors:  R David G Leslie; Robert M Cohen
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

9.  The significance of routine laboratory analyses in the assessment of teenage girls with eating disorders and weight loss.

Authors:  I Swenne
Journal:  Eat Weight Disord       Date:  2004-12       Impact factor: 4.652

10.  Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.

Authors:  Roy W Beck; Richard M Bergenstal; Tonya D Riddlesworth; Craig Kollman; Zhaomian Li; Adam S Brown; Kelly L Close
Journal:  Diabetes Care       Date:  2018-10-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.